Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.73 |
| ▸ | CA2 | P00918 | 3/20 | 0.73 |
| ▸ | CA9 | Q16790 | 3/20 | 0.73 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.73 |
| ▸ | CA1 | P00915 | 2/20 | 0.73 |
| ▸ | CA3 | P07451 | 2/20 | 0.73 |
| ▸ | CA4 | P22748 | 2/20 | 0.73 |
| ▸ | GLA | P06280 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 10/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL28409164 | 1.00 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL9617820 | 0.97 | CA12 (0.69) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL27342954 | 0.91 | CA12 (0.61) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL1309339 | 0.89 | — | — | |
| Phenol SCHEMBL27623791 | 0.89 | CA12 (0.92) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL10754831 | 0.86 | CA12 (0.85) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL17867531 | 0.86 | CA12 (0.85) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL29142716 | 0.86 | CA12 (0.85) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL1081744 | 0.86 | — | — | |
| Phenol SCHEMBL2784393 | 0.86 | CA12 (0.85) | CA12CA2CA9CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554993-A1 | ADHESIVE COMPOSITION | DDP Specialty Electronic Materials US, LLC (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024015165-A1 | ADHESIVE COMPOSITION | DDP SPECIALTY ELECTRONIC MATERIALS US, LLC (US) | 2024-01-18 | — | — | WO | claimed |
| US-20230374043-A1 | Hexadeca Ammonium-Modified Phthalocyanine and Preparation Method and Use Thereof as Photodynamic Drug | FUZHOU UNIVERSITY (CN) | 2023-11-23 | — | — | US | claimed |
| CN-114149774-A | High-temperature-resistant high-strength resin glue | 常熟市石油固井工具有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-112028901-B | Cetyl ammonium group modified phthalocyanine, preparation method thereof and application thereof as photodynamic medicament | 福州大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112028901-A | Cetyl ammonium group modified phthalocyanine, preparation method thereof and application thereof as photodynamic medicament | 福州大学 | 2020-12-04 | — | — | CN | claimed |
| CN-102482589-B | A method and a solution for treating hydrocarbon containing mercaptans | MERICHEM CO | 2015-05-20 | — | — | CN | claimed |
| CN-102333783-B | Methylene pyrrole boron complex compound and organic electroluminescent element using same | IDEMITSU KOSAN CO.,LTD. (JP) | 2014-10-08 | — | — | CN | claimed |
| CN-102664054-B | X-ray absorption grate manufacturing method and filling device thereof | SHENZHEN UNIVERSITY (CN) | 2014-10-01 | — | — | CN | claimed |
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | claimed |
| CN-1231502-C | Multinuclear metallocene catalyst | HONAM PETROCHEMICAL CORP (KR) | 2005-12-14 | — | — | CN | claimed |
| CN-1633437-A | Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic | MOLTENI & C (IT) | 2005-06-29 | — | — | CN | claimed |
| CN-1592748-A | Separation of regioisomers of metal phthalocyanines | MOLTENI & C (IT) | 2005-03-09 | — | — | CN | claimed |
| CN-1179961-C | Sulfonamides for the treatment of endothelin mediated diseases | ��ɪϣ����ҩ��˾ | 2004-12-15 | — | — | CN | claimed |
| CN-1505479-A | Pesticide composition containing oxalic acid | ������ɽ���� | 2004-06-16 | — | — | CN | claimed |
| CN-1489601-A | Multinuclear metallocene catalyst | ������ѧ��ʽ���� | 2004-04-14 | — | — | CN | claimed |
| EP-1164135-B1 | Substituted metal-phthalocyanines, their preparation and the use thereof | MOLTENI & C (IT) | 2004-02-18 | — | — | EP | claimed |
| CN-1424625-A | Chemical amplitude increased positive corrosionproof agent composition | SUMITOMO CHEMICAL CO (JP) | 2003-06-18 | — | — | CN | claimed |
| CN-1253560-A | Sulfonamides for the treatment of endothelin mediated diseases | TEXA BIOTECHNOLOGY CORP (US) | 2000-05-17 | — | — | CN | claimed |
| CN-1098107-A | modified oligodeoxynucleotides, their preparation and their therapeutic use | SANKYO CO (JP) | 1995-02-01 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230374043-A1 | Hexadeca Ammonium-Modified Phthalocyanine and Preparation Method and Use Thereof as Photodynamic Drug | SLC30A7, SLC7A1, PTMA | CA12 2690/4885CA2 1108/4885CA9 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.